WallStreetZenWallStreetZen

NASDAQ: ATRA
Atara Biotherapeutics Inc Earnings & Revenue

ATRA past revenue growth

How has ATRA's revenue growth performed historically?
Company
-39.63%
Industry
82.48%
Market
19.08%
ATRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ATRA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ATRA earnings and revenue history

Current Revenue
$34.7M
Current Earnings
-$233.1M
Current Profit Margin
-671.7%

ATRA Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when ATRA announces earnings.

ATRA Return on Assets

Current Company
-121.7%
Current Industry
3.2%
ATRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATRA Return on Capital Employed

Current Company
1,478.71%
Current Industry
-42.4%
ATRA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATRA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATRA$34.70M-$211.11M-$233.11M+206.22%N/A
MLEC$2.90M-$6.25M-$6.48MN/AN/A
AEON$0.00-$323.91M-$323.95MN/AN/A
INAB$0.00-$28.50M-$31.04MN/AN/A
MTNB$0.00-$22.30M-$23.25M-100.00%N/A

ATRA earnings dates

Next earnings date
Aug 6, 2024

Atara Biotherapeutics Earnings & Revenue FAQ

What were ATRA's earnings last quarter?

On Invalid Date, Atara Biotherapeutics (NASDAQ: ATRA) reported Q1 2024 earnings per share (EPS) of -$5.75, up 68.06% year over year. Total Atara Biotherapeutics earnings for the quarter were -$31.75 million. In the same quarter last year, Atara Biotherapeutics's earnings per share (EPS) was -$18.00.

If you're new to stock investing, here's how to buy Atara Biotherapeutics stock.

What was ATRA's earnings growth in the past year?

As of Q2 2024, Atara Biotherapeutics's earnings has grown year over year. Atara Biotherapeutics's earnings in the past year totalled -$233.11 million.

What is ATRA's earnings date?

Atara Biotherapeutics's earnings date is Invalid Date. Add ATRA to your watchlist to be reminded of ATRA's next earnings announcement.

What was ATRA's revenue last quarter?

On Invalid Date, Atara Biotherapeutics (NASDAQ: ATRA) reported Q1 2024 revenue of $27.36 million up 2,131.4% year over year. In the same quarter last year, Atara Biotherapeutics's revenue was $1.23 million.

What was ATRA's revenue growth in the past year?

As of Q2 2024, Atara Biotherapeutics's revenue has grown -39.63% year over year. This is 122.11 percentage points lower than the US Biotechnology industry revenue growth rate of 82.48%. Atara Biotherapeutics's revenue in the past year totalled $34.70 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.